- Super User
- Progress
- Read Time: 1 min
- Hits: 0
A selection visit was successfully completed to participate in a phase III clinical trial for sublingual immunotherapy of tree pollen allergy for children from 5 to 17 years old.
A selection visit was successfully completed to participate in a phase III clinical trial for sublingual immunotherapy of tree pollen allergy for children from 5 to 17 years old.
Our Study Site was invited to participate in clinical trials conducted by the Japanese pharmaceutical company Astellas Pharma
Our Study Site was invited to participate in clinical trials conducted by the international pharmaceutical company Biogen.
Our Study Site ranked 6th in the world in recruiting patients to study 14-433 to evaluate the efficacy and safety of the drug ABT-494 in patients with Crohn's disease.